Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 16 June 1989:
Vol. 244. no. 4910, pp. 1342 - 1344
DOI: 10.1126/science.2499928
Prev | Table of Contents | Next

Articles

Science, Vol 244, Issue 4910, 1342-1344
Copyright © 1989 by American Association for the Advancement of Science

articles

Recombinant gene expression in vivo within endothelial cells of the arterial wall

EG Nabel, G Plautz, FM Boyce, JC Stanley, and GJ Nabel

Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0650.

A technique for the transfer of endothelial cells and expression of recombinant genes in vivo could allow the introduction of proteins of therapeutic value in the management of cardiovascular diseases. Porcine endothelial cells expressing recombinant beta-galactosidase from a murine amphotropic retroviral vector were introduced with a catheter into denuded iliofemoral arteries of syngeneic animals. Arterial segments explanted 2 to 4 weeks later contained endothelial cells expressing beta-galactosidase, an indication that they were successfully implanted on the vessel wall.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Defining the potential for cell therapy for vascular disease using animal models.
R. Gulati and R. D. Simari (2009)
Dis. Model. Mech. 2, 130-137
   Abstract »    Full Text »    PDF »
Current State and Perspective on Medical Treatment of Critical Leg Ischemia: Gene and Cell Therapy.
J. Emmerich (2005)
International Journal of Lower Extremity Wounds 4, 234-241
   Abstract »    PDF »
Gene Therapy for the Extension of Vein Graft Patency: A Review.
A. Chandiwal, V. Balasubramanian, Z. K. Baldwin, M. S. Conte, and L. B. Schwartz (2005)
Vascular and Endovascular Surgery 39, 1-14
   Abstract »    PDF »
Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease.
L. G. Melo, M. Gnecchi, A. S. Pachori, D. Kong, K. Wang, X. Liu, R. E. Pratt, and V. J. Dzau (2004)
Arterioscler Thromb Vasc Biol 24, 1761-1774
   Abstract »    Full Text »    PDF »
Local Gene Transfer of phVEGF-2 Plasmid by Gene-Eluting Stents: An Alternative Strategy for Inhibition of Restenosis.
D. H. Walter, M. Cejna, L. Diaz-Sandoval, S. Willis, L. Kirkwood, P. W. Stratford, A. B. Tietz, R. Kirchmair, M. Silver, C. Curry, et al. (2004)
Circulation 110, 36-45
   Abstract »    Full Text »    PDF »
Nitric Oxide Synthase Gene Transfer as a Tool to Study Biology of Endothelial Cells.
Z. S. Katusic, N. M. Caplice, and K. A. Nath (2003)
Arterioscler Thromb Vasc Biol 23, 1990-1994
   Abstract »    Full Text »    PDF »
What can cardiovascular gene transfer learn from genomics: and vice versa?.
T. H. Kim, K. A. Skelding, E. G. Nabel, and R. D. Simari (2002)
Physiol Genomics 11, 179-182
   Abstract »    Full Text »    PDF »
Vascular Gene Therapy: A Reality of the 21st Century.
B. S. Zuckerbraun and E. Tzeng (2002)
Arch Surg 137, 854-861
   Abstract »    Full Text »    PDF »
Coronary in-stent restenosis: Current status and future strategies.
H. C. Lowe, S. N. Oesterle, and L. M. Khachigian (2002)
J. Am. Coll. Cardiol. 39, 183-193
   Abstract »    Full Text »    PDF »
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries.
P. Golino, P. Cirillo, P. Calabro', M. Ragni, D. D'Andrea, E. V. Avvedimento, F. Vigorito, N. Corcione, F. Loffredo, and M. Chiariello (2001)
J. Am. Coll. Cardiol. 38, 569-576
   Abstract »    Full Text »    PDF »
Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon?.
D. W. Losordo and J. M. Isner (2001)
J. Am. Coll. Cardiol. 37, 2131-2135
   Full Text »    PDF »
Gene Therapy for Cardiovascular Disease.
S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz (2000)
Seminars in Cardiothoracic and Vascular Anesthesia 4, 289-300
   Abstract »    PDF »
Gene Therapy for Restenosis.
M. R. Kibbe, T. R. Billiar, and E. Tzeng (2000)
Circ. Res. 86, 829-833
   Full Text »    PDF »
Phase I Study of Direct Intralesional Gene Transfer of HLA-B7 into Metastatic Renal Carcinoma Lesions.
B. I. Rini, L. M. Selk, and N. J. Vogelzang (1999)
Clin. Cancer Res. 5, 2766-2772
   Abstract »    Full Text »    PDF »
Highly efficient liposome-mediated gene transfer of inducible nitric oxide synthase in vivo and in vitro in vascular smooth muscle cells.
K. Veit, J.-P. Boissel, M. Buerke, T. Grosser, J. Meyer, and H. Darius (1999)
Cardiovasc Res 43, 808-822
   Abstract »    Full Text »    PDF »
Liposomal Lipid and Plasmid DNA Delivery to B16/BL6 Tumors after Intraperitoneal Administration of Cationic Liposome DNA Aggregates.
D. L. Reimer, S. Kong, M. Monck, J. Wyles, P. Tam, E. K. Wasan, and M. B. Bally (1999)
J. Pharmacol. Exp. Ther. 289, 807-815
   Abstract »    Full Text »
Endothelial Implants Inhibit Intimal Hyperplasia After Porcine Angioplasty.
H. M. Nugent, C. Rogers, and E. R. Edelman (1999)
Circ. Res. 84, 384-391
   Abstract »    Full Text »    PDF »
Molecular advances in cardiac and cardiovascular disease.
A. Basile-Borgia, J. H Abel, and H. Mahloogi (1999)
Perfusion 14, 89-99
   Abstract »    PDF »
Vascular Gene Transfer : From Bench to Bedside.
I. J. Kullo, R. D. Simari, and R. S. Schwartz (1999)
Arterioscler Thromb Vasc Biol 19, 196-207
   Full Text »    PDF »
Is Gene Therapy for Hypertension Possible?.
M. I. Phillips (1999)
Hypertension 33, 8-13
   Full Text »    PDF »
A new approach to fighting cancer?.
T. N. Sato (1998)
PNAS 95, 5843-5844
   Full Text »    PDF »
Gene Therapy for Restenosis : Getting Nearer the Heart of the Matter.
S. Baek and K. L. March (1998)
Circ. Res. 82, 295-305
   Abstract »    Full Text »    PDF »
Gene Therapy for Restenosis : Are We Ready?.
M. B. DeYoung and D. A. Dichek (1998)
Circ. Res. 82, 306-313
   Abstract »    Full Text »    PDF »
Gene Therapy of Restenosis : Promise and Perils.
P. Libby (1998)
Circ. Res. 82, 404-406
   Full Text »    PDF »
Liposome mediated gene transfer into the rat oesophagus.
R M Schmid, H Weidenbach, G F Draenert, S Liptay, H Luhrs, and G Adler (1997)
Gut 41, 549-556
   Abstract »    Full Text »    PDF »
Optimal techniques for arterial gene transfer.
L. J Feldman and G. Steg (1997)
Cardiovasc Res 35, 391-404
   Abstract »    Full Text »    PDF »
Gene therapy for arterial thrombosis.
G. Vassalli and D. A Dichek (1997)
Cardiovasc Res 35, 459-469
   Abstract »    Full Text »    PDF »
Transfection of human endothelial cells.
F. C Tanner, D. P Carr, G. J Nabel, and E. G Nabel (1997)
Cardiovasc Res 35, 522-528
   Abstract »    Full Text »    PDF »
The DispatchTM catheter as a delivery tool for arterial gene transfer.
O. Tahlil, M. Brami, L. J Feldman, D. Branellec, and Ph.G. Steg (1997)
Cardiovasc Res 33, 181-187
   Abstract »    Full Text »    PDF »
In Vivo Gene Transfer and Gene Modulation in Hypertension Research.
V. J. Dzau and M. Horiuchi (1996)
Hypertension 28, 1132-1137
   Abstract »    Full Text »
Gene Therapy for Cerebral Vascular Disease.
D. D. Heistad and F. M. Faraci (1996)
Stroke 27, 1688-1693
   Abstract »    Full Text »
GENE THERAPY FOR DONOR HEARTS: EX VIVO LIPOSOME-MEDIATED TRANSFECTION.
J. Dalesandro, H. Akimoto, C. M. Gorman, T. O. McDonald, R. Thomas, H. D. Liggitt, and M. D. Allen (1996)
J. Thorac. Cardiovasc. Surg. 111, 416-422
   Abstract »    Full Text »
Enhanced In Vivo Antithrombotic Effects of Endothelial Cells Expressing Recombinant Plasminogen Activators Transduced With Retroviral Vectors.
D. A. Dichek, J. Anderson, A. B. Kelly, S. R. Hanson, and L. A. Harker (1996)
Circulation 93, 301-309
   Abstract »    Full Text »
CARDIAC GENE TRANSFER BY INTRACORONARY INFUSION OF ADENOVIRUS VECTOR--MEDIATED REPORTER GENE IN THE TRANSPLANTED MOUSE HEART.
J. Lee, H. Laks, D. C. Drinkwater, A. Blitz, L. Lam, Y. Shiraishi, P. Chang, T. A. Drake, and A. Ardehali (1996)
J. Thorac. Cardiovasc. Surg. 111, 246-252
   Abstract »    Full Text »
Potential Gene Therapy Strategies in the Treatment of Cardiovascular Disease.
R. T. Rowland, J. C. Cleveland Jr, X. Meng, A. H. Harken, and J. M. Brown (1995)
Ann. Thorac. Surg. 60, 721-728
   Abstract »    Full Text »
Local Delivery of Vascular Endothelial Growth Factor Accelerates Reendothelialization and Attenuates Intimal Hyperplasia in Balloon-Injured Rat Carotid Artery.
T. Asahara, C. Bauters, C. Pastore, M. Kearney, S. Rossow, S. Bunting, N. Ferrara, J. F. Symes, and J. M. Isner (1995)
Circulation 91, 2793-2801
   Abstract »    Full Text »
Genetic Models of Human Vascular Disease.
V. J. Dzau, G. H. Gibbons, B. K. Kobilka, R. M. Lawn, and R. E. Pratt (1995)
Circulation 91, 521-531
   Abstract »    Full Text »
Gene Therapy for Cardiovascular Disease.
E. G. Nabel (1995)
Circulation 91, 541-548
   Full Text »
Gene therapy for vascular smooth muscle cell proliferation after arterial injury.
T Ohno, D Gordon, H San, V. Pompili, M. Imperiale, G. Nabel, and E. Nabel (1994)
Science 265, 781-784
   Abstract »    PDF »
Vascular disease: the next target for local molecular therapeutics.
J McEwan, A Henney, and S Humphries (1994)
BMJ 308, 995-996
   Full Text »
Tissue engineering.
R Langer and J. Vacanti (1993)
Science 260, 920-926
   Abstract »    PDF »
Cardiothoracic Surgery.
A. H. Harken and D. E. Harken (1992)
JAMA 268, 337-338
   Abstract »    PDF »
Gene Therapy in Humans: A New Era Begins.
W. N. Kelley (1991)
Ann Intern Med 114, 697-698
   Abstract »    PDF »
Site-specific gene expression in vivo by direct gene transfer into the arterial wall.
E. Nabel, G Plautz, and G. Nabel (1990)
Science 249, 1285-1288
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)